Overview

A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2025-09-01

Target enrollment:

Participant gender:

Summary

to compare facial sebaceous gland morphology after 3 months of clascoterone cream 1% treatment and to compare facial sebum constituents at baseline to facial sebum constituents after 3 months of clascoterone cream 1% treatment

Phase:

PHASE4

Details

Lead Sponsor:

Sun Pharmaceutical Industries Limited

Treatments:

Clascoterone